United Therapeutics Corporation Debt Securities, Available-for-sale
United Therapeutics Corporation (UTHR) had Debt Securities, Available-for-sale of $2.65 billion as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Balance Sheet › Assets › Investments
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2022-02-24
- 2021-12-31: Debt Securities, Available-for-sale $2.65B.
- 2021-09-30: Debt Securities, Available-for-sale $2.62B.
- 2021-06-30: Debt Securities, Available-for-sale $2.29B.
- 2021-03-31: Debt Securities, Available-for-sale $2.27B.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2021-12-31 | $2.65B 10-K · filed 2022-02-24 | |
| 2021-09-30 | $2.62B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $2.29B 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $2.27B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $2.25B 10-K · filed 2022-02-24 | |
| 2020-09-30 | $2.12B 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $1.85B 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $1.51B 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $1.45B 10-K · filed 2021-02-24 | |
| 2019-09-30 | $1.52B 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $1.27B 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $1.22B 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $1.15B 10-K · filed 2020-02-26 | $1.15B 10-K · filed 2019-02-27 |
| 2018-09-30 | $1.14B 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $1.08B 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $715.10M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $737.40M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |